Local recurrence – free survival was 50 percent for those who. Both therapies and 30 percent for those who received radiation alone Also conducted a clinical study at Duke University, the previously irradiated patients with superficial tumors had 23.5 percent complete response when treated with radiation a return rate of 68.2 percent in patients treated with hyperthermia plus radiation compared. (See the Journal of Clinical Oncology, May 2005.. – Clinical Evidence and Advanced Technology support hyperthermia therapy for the annual ACRO Conference stressed in a clinical trial in the UK, the Netherlands and Canada conducted with 306 patients with superficial localized breast cancer, patients hyperthermia hyperthermia and radiotherapy complete response rate of 59 percent to 41 percent for radiation radiotherapy alone.
‘Our innovations are perfect demonstrations of Philips ‘ commitment to enable healthcare providers to devote attention to their patients, not just the technology,’says Steve Rusckowski, CEO of Philips Medical Systems. ‘The new Brilliance iCT scanner announced today was specifically designed by Philips to make the work of the clinicians easier and improve the experience of patients. ‘.The blood trial announcing quick stroke diagnosisA quick and cheap blood test might soon be to help doctors said if a patient is helping a stroke the right treatment the right treatment as soon as practicable. Upcoming releases might even able to of distinguishing between different types of strokes.
Year-old man pelvi – abdominal malignant inflammatory myofibroblastic tumorInflammatory myofibroblastic tumor is a rare benign with a locally aggressive conduct but malignant change in is rare. Such an a rare tumor occurs in a 14 – year-old man is rated clinical presentations of abdominal pain and weight loss previously previously.